Literature DB >> 15057218

Recognition of tumor blood vessel normalization as a new antiangiogenic concept.

Kurt Hellmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15057218     DOI： 10.1038/nm0404-329a

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  4 in total

Review 1.  Extracellular matrix, inflammation, and the angiogenic response.

Authors:  Alicia G Arroyo; M Luisa Iruela-Arispe
Journal:  Cardiovasc Res       Date:  2010-02-12       Impact factor: 10.787

2.  Enhanced Tumor Control with Combination mTOR and PD-L1 Inhibition in Syngeneic Oral Cavity Cancers.

Authors:  Ellen C Moore; Harrison A Cash; Andria M Caruso; Ravindra Uppaluri; James W Hodge; Carter Van Waes; Clint T Allen
Journal:  Cancer Immunol Res       Date:  2016-04-13       Impact factor: 11.151

3.  The ACTIVE study protocol: apatinib or placebo plus gefitinib as first-line treatment for patients with EGFR-mutant advanced non-small cell lung cancer (CTONG1706).

Authors:  Zhonghan Zhang; Fan Luo; Yang Zhang; Yuxiang Ma; Shaodong Hong; Yunpeng Yang; Wenfeng Fang; Yan Huang; Li Zhang; Hongyun Zhao
Journal:  Cancer Commun (Lond)       Date:  2019-11-07

4.  Structural adaptation and heterogeneity of normal and tumor microvascular networks.

Authors:  Axel R Pries; Annemiek J M Cornelissen; Anoek A Sloot; Marlene Hinkeldey; Matthew R Dreher; Michael Höpfner; Mark W Dewhirst; Timothy W Secomb
Journal:  PLoS Comput Biol       Date:  2009-05-29       Impact factor: 4.475
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.